|
|
Keep your cool
A team of scientists at Oxford University and
NovaBio-Pharma Technologies believe they have
discovered a way of keeping vaccines stable without
refrigeration. Matt Cottingham, senior virologist
at the Jenner Institute, Oxford University, explains
the work. view
pdf
|
A problem shared
Consolidating certain functional and business
support activities into a shared organisation
can be an effective way of pursuing both growth
and cost-reduction goals, write Deloitte’s
Jessica Golden and Aprajita Rathore. view
pdf
|
|
Cold comfort
Following the revelation that electricity prices
in sub-Saharan Africa are set to rise for the
next three years, Wayne Basson of international
trade solutions company Coface looks at how pharmaceutical
and cold storage companies can stay competitive
in the face of rising overheads. view
pdf
|
A future free from needles
Needle-based injections have formed a huge part
of the world’s medical history but that’s
set to change, according to GlobalData. view
pdf
|
Money where the mouth is
The oral sector is expected to continue its dominance
of the drug delivery market, say GBI Research.
view
pdf
|
|
Keep your cool
A team of scientists at Oxford University and
NovaBio-Pharma Technologies believe they have
discovered a way of keeping vaccines stable without
refrigeration. Matt Cottingham, senior virologist
at the Jenner Institute, Oxford University, explains
the work. view
pdf
|
Take your medicine
GlaxoSmithKline’s James Hagan on how healthcare
can reduce adverse environmental impacts from
operations, and lower costs and prices to provide
greater access to medicines in a way that is business-based,
not philanthropy-based. view
pdf
Quality control
Quality by design may not be new but it is still
making waves in the industry, where it has the
potential to profoundly change how drugs are discovered,
developed, manufactured and regulated. Nic Paton
speaks to Sven Stegemann, director for pharmaceutical
business development at Pfizer’s Capsugel
division. view
pdf
|
Picture perfect
Positron emission tomography has potential uses
in drug development and the treatment of various
pathologies, including cancer. The National Cancer
Research Institute PET Research Network gives
a snapshot of the technology. view
pdf
In the US pipeline
While the total number of FDA approvals is remaining
fairly constant year-on-year, closer inspection
shows that within certain categories of drugs
the story is far from static, as GlobalData reveals.
view
pdf
|
|
Don’t forget the fine print
The readability and usability of medicine package
leaflets has been a source of consternation for
patient groups for years. Klaus Menges of the
Federal Institute for Medicinal Products and Medical
Devices in Germany examines what needs to change
and how new guidelines could help. view
pdf
Operation drug bust
Due to the global expansion of the pharmaceuticals
market, counterfeit drugs are an increasing problem.
So how can companies ensure the integrity of their
products? Katherine Eban, author of a book on
the subject, blows the whistle on the black market.
view
pdf
|
Scandinavian hot spots
The Scandinavian sector has enjoyed sustained
growth in recent years. Frost & Sullivan’s
Ranjith Gopinathan examines why. view
pdf
|
News
A round-up of all the latest business and healthcare
news. view
pdf |
